2021 Liver Cancer News
December 2021
Study Uses Metabolomics To Discriminate Drug-Induced Liver Injury Phenotypes
Puerto Ricans Continue To Be At Higher Risk Of Developing Hepatocellular Cancer, Study Indicates
FDA Grants Fast Track Designation To Liocyx-M004 For HBV-Related Hepatocellular Carcinoma
Are Immune Checkpoint Inhibitors Better Than Standard Care For Unresectable HCC?
With A ‘Biological Computer,’ Scientists Look To Target Cancer While Sparing Healthy Cells
Part 2: Factors For Considering Transplant Or Immunotherapy In HCC
Last Liver Cancer Patient In Phase II Trial Of Namodenoson Found Cleared Of All Lesions
HCC Prevention Should Be Targeted To Patients With Moderate Fibrosis
Precisely Targeting Liver Cancer With Logic-Gated Gene Therapy
Who Is At Risk For Liver Cancer After Hepatitis C Treatment?
Rates Of HCC Rising In Black Patients Without Cirrhosis
Part 1: Using Scans And Biopsy To Diagnose HCC
CRISPR/Cas9 Gene-Editing Boosts Effectiveness Of Ultrasound Cancer Therapy
November 2021
Combinatorial Serum Protein Panel ‘Promising’ in Early HCC Detection
Promising Treatment for Advanced Hepatocellular Carcinoma Enters Clinical Trials
FOLFOX Chemotherapy is Superior to TACE in Liver Cancer
High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD
HCC Reoccurs in 1 of 7 Following Liver Transplantation
Updates to Adjuvant and Neoadjuvant Therapy in Early HCC
Finding the Optimal Therapeutic Sequence for Advanced Hepatocellular Carcinoma
A Target for Potential Cancer Drugs May, In Fact, Worsen Disease
FDA Clears Pharmaxis Cancer Drug to Progress to Phase 2 Study in Liver Cancer
Goals for TACE and Immunotherapy Trial in Intermediate-Stage HCC
Kerala's local herb 'Manathakkali' approved for liver cancer, research gets US FDA nod
Novel Blood-Based Panel Highly Effective for Early-Stage HCC
October 2021
Weight Loss Medications May Reduce Risk For Cirrhosis And Hepatocellular Carcinoma
Early-Stage Immunotherapy Use In HCC Produces High Response Rate
New System Created For Targeted Delivery Of Anti-Cancer Drugs
Liver Cancer Screening: Detecting A ‘Silent’ Condition
Liver Cancer Awareness Q&A With Ariel Jaffe, MD
Dr. Heimbach On The Need For Multidisciplinary Care In HCC
October Is Liver Cancer Awareness Month
External-beam Radiation Therapy Underused For People With Liver Cancer Awaiting Transplant
Arterial Chemo Tops Chemoembolization For Large Liver Tumors
Sure Signs You May Have Liver Damage, Say Experts
Abou-Alfa Gives Expert Insights For Liver Cancer Awareness Month
UQ Start-Up Secures $1.3 Million Seed Investment To Develop New Treatment For Liver Disease
MiRNA Expression in Cirrhosis and Liver Cancer
Vogel Discusses Real-World Survival Data Of Immunotherapy In HCC
Tremelimumab/Durvalumab Combo Safe And Efficacious For Unresectable Hepatocellular Carcinoma
Roundtable Discussion: Abou-Alfa And Participants Cover Biopsies And Treatment In HCC
Ronawk Using Stem Cell Tech Developed At Olathe Lab To Advance Liver Cancer Research In Turkey
Nivolumab Continues To Elicit Durable Responses In Advanced HCC
Optimizing Precision Medicine In HCC
Roundtable Discussion: Finn Explores Treatment For Unresectable HCC
Therapeutic Approaches For The Treatment Of Hepatocellular Carcinoma
September 2021
How to Choose Second-Line Treatment For Hepatocellular Carcinoma
PSMA PET Imaging More Accurate Than CT In Detecting Hepatocellular Carcinoma
Pembrolizumab Extends OS In Pretreated Hepatocellular Carcinoma
Deep Learning Model Could Predict OutcomesFor HCC Patients
Dr. Harris On Remaining Questions With Treatment Sequencing In HCC
Merck Grabs Lifeline For Problematic Keytruda Liver Cancer Approval Thanks To Asian Trial Win
Cancer Care Innovations: Recently Approved Therapy Improves The Odds For Liver Cancer Patients
Owkin And Cleveland Clinic Develop AI Model That Predicts Liver Cancer Prognosis
Estimating Surgical Outcomes For Hepatocellular Carcinoma
Blood Test For Liver Cancer Shows Promise
Researchers Discover Genetic And Epigenetic ‘Origin Story’ Of Pediatric Liver Cancer
Unique Sugar Structures Could Identify Early-Stage Liver Cancer
Predicting Which Patients Will Develop HCC After HCV Treatment
New Nano Particles Suppress Resistance To Cancer Immunotherapy
First UK Patients Treated For Liver Cancer Using Ultrasound Technology
Maintaining Virologic Response Following HBV Treatment Reduces HCC Risk
Thiazolidinedione Use Associated With Decreased HCC Risk In Asian Patients With T2D
Poorly Differentiated Tumor Size Linked To Worse Prognosis In HCC, Study Finds
FDA Grants Breakthrough Device Designation To The NovoTTF-200T™ System For Advanced Liver Cancer
Dr. Llovet On Considering Safety Profiles During Treatment Selection In HCC
Adaptimmune Updates Data From Its Phase 1 Trial For Liver Cancer At ILCA Showing Clinical Benefit
Checkpoint Inhibition Plus Ablation Shows Promise In Advanced HCC
Dr. Pinato On Guidelines For Toxicity Management In HCC
Investigators Look To Overcome Resistance In Advanced HCC With Triplet Combinations
Understanding The Molecular Diverse Makeup Of Hepatocellular Carcinoma
Multidisciplinary Approach Important For Successful HCC Care
Predictive Biomarkers For Checkpoint Inhibition Remain Unmet Need In HCC
Dr. Harris On IMbrave150 Results With Atezolizumab/Bevacizumab In HCC
Neoadjuvant Cabozantinib/Nivolumab Leads To Improved Resection Rates In HCC
Radio Waves Show Promise In Treating Hepatocellular Carcinoma
Tislelizumab’s Activity In Pretreated HCC Leads To Randomized Phase 3 Trial
August 2021
Results Of The Study Of Tislelizumab In Unresectable HCC
Medivir Receives Regulatory Approval From MHRA For Phase 1/2a Combination Study With MIV-818
A Turncoat Protein Allows Viruses To Ride Roughshod In The Liver, Paving The Way To Cancer
Identification Of Novel Potential Biomarker For Hepatocellular Carcinoma
Breakthrough Cancer Treatment Now Being Offered At Enloe Medical Center
Combination Treatment May Make Liver Cancer Patients Eligible For Curative Surgery
Determining The Efficacy Of Neoadjuvant Cemiplimab In Hepatocellular Carcinoma
Hub Candidate Network For Hepatocellular Carcinoma
Advice On Molecular Testing And Sequencing In Unresectable HCC
Study Highlights Exact Sciences’ Blood Test For Liver Cancer
Utilizing Tislelizumab To Treat Unresectable Hepatocellular Carcinoma
Sintilimab Plus IBI305 For Hepatitis B Virus-Positive Hepatocellular Carcinoma
Dr. Harris On The Adoption Of Immunotherapy In Advanced HCC
Dr. Wang On The Rationale For Viral Hepatitis Screening To Prevent HCC
Yale’s Digestive Diseases Faculty Acknowledged For Expertise
Magnetic Nanoparticles Could Enhance The Efficacy Of Cancer Immunotherapy
Diagnostic Testing For Early-Stage HCC
Global Real-World Data Establish TheraSphere Y-90 As Optimal Choice For HCC
Older Liver Cancer Survivors Are Less Informed About Life After Cancer
Digital Health Platform 111 Signs Deal To Build Online Liver Cancer Management Platform
Biotech Company Looking To Detect HCC Early With Liquid Biopsy Based On Microbiome
Direct Acting Antivirals Safe, Effective For HCC Patients
Neoadjuvant Cabozantinib/Nivolumab May Make Resection Possible For Some Patients With Liver Cancer
Curing Hepatitis C Improves Liver Cancer Outcomes
Singapore Study To Aid Early Detection Of Primary Liver Cancer
Study Shows Safety And Efficacy Of Radio-Wave Therapy For Liver Cancer Patients
July 2021
Drug Combination Could Make Curative Surgery Possible for Some Liver Cancer Patients
World Hepatitis Day 2021 – All You Need to Know About Hepatitis and Liver Cancer
What to Know About Tecentriq (Atezolizumab)
Chinese Study Finds That Sintilimab and Biosimilar Bevacizumab Prolong HCC PFS
Donafenib Bests Sorafenib in Chinese Patients With Advanced Hepatocellular Carcinoma
Treatment for Liver Cancer: From Sorafenib to Natural Products.
2 Novel Studies Set to Address Unanswered Questions in Liver Cancer
Researchers Discover a Culprit Behind Aggressive Liver Cancer
Study Sheds Light on Precise Personalized Hepatocellular Carcinoma Medicine
COVID-19 Pandemic Had Significant Impact on Liver Cancer Screenings and Care
Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study
TARE Proves Effective as First-Line Treatment for HCC
Fourth-Generation Chimeric Antigen Receptor T Cells for Hepatocellular Carcinoma
Study Identifies MAGEA3 as Novel Therapeutic Target in Hepatocellular Carcinoma
Novocure Issues Final Phase 2 Liver Cancer Results; Plans Phase 3 Trial
June 2021
Frontline Lenvatinib Shows Superiority to Sorafenib in HCC in Real-World Setting
Patient-Reported Outcomes With Atezolizumab/Bevacizumab Indicative of Benefit in Unresectable HCC
Glucose Variability Predicts HCC in Patients with Diabetes
Cabozantinib Plus Atezolizumab Extends PFS For Frontline HCC In COSMIC-312 Trial
Genetic Tool Possible Key To Improving Liver Cancer Treatments
Study Suggests Better Prediction Model For Selecting Transplant Patients To Treat Liver Cancer
Genetic Study Of Liver Cancer Reveals New Drug Target
Camrelizumab And Apatinib Shows Long-Term OS Benefit In Advanced HCC
Study Suggests Drinking 3 To 4 Cups Of Coffee A Day Reduces Risk Of Liver Cancer And Disease
Byvasda Shows Promise In Combination With Sintilimab For Patients With HCC
Berry Oncology Partners With Alibaba Health To Create China's Early Cancer Screening Ecosystem
University Of Louisville Receives $11.3 Million From NIH For Liver Research Center
Hepatic Arterial Infusion Chemotherapy Prolongs OS Vs. Sorafenib In HCC Subset
HBV Suppression Lowers Liver Cancer Rates In Patients Coinfected With HIV
Liver Cancer Patients To Benefit From Microwave Ablation At QAH
Hepatocellular Carcinoma & HIV
Atezolizumab-Bevacizumab Better Than Sorafenib In Advanced HCC
Surface Oncology, Roche Studying IL-27 Antibody With Tecentriq, Avastin In Liver Cancer
Geneos Therapeutics Announces Clinical Updates On Personalized Cancer Vaccine Program
Therasphere Proves Highly Effective In HCC
Ultrasound Technology Developed At U-M Now In Clinical Trials For Liver Cancer
Investigators Are Exploring Neoadjuvant And Adjuvant Therapy In HCC
Neoadjuvant Cemiplimab Induces Tumor Necrosis In Resectable HCC
May 2021
Oncotech Develops AI-Powered Real-Time Mobile Cancer Screening And Detection System
Once Only Available In Major Cities, Robot-Assisted Liver Cancer Resection Now Performed In RI
Medivir Announces The Design Of Its Upcoming MIV-818 Combination Study
The Role Of Probiotics In Cancer Prevention Receives Increasing Attention
Atezolizumab-Bevacizumab Better Than Sorafenib In Advanced HCC
Resection May Be Best Option In Patient Subset With Hepatocellular Carcinoma And PVTT
Non-Invasive Screening: Innovative Technology May Halt Progression Of Liver Disease To Liver Cancer
Fluorescent Dye Helps Guide Pediatric Liver Tumor Resection
Neoadjuvant Cemiplimab Shows Promise As HCC Treatment
More Reimbursement Needed For Hepatocellular Carcinoma
Analysis Correlates Cost Of Therapy With Improvement In Outcomes For Patients With HCC
Oregon State Researchers Discover New Class Of Cancer Fighting Compounds
Dr. Patel On Selecting Patients For Treatment With Atezolizumab/Bevacizumab In HCC
Neoadjuvant Libtayo Shows Promise For Patients With Hepatocellular Carcinoma
Apatinib As Second-line Or Later Therapy In Patients With Advanced Hepatocellular Carcinoma (AHELP)
Vuno’s AI Platform Finds Biomarker For Survival Of Liver Cancer Patients
How Tumor Cells Control Their Environment To SurviveLandmark Study Launched To Detect Liver Cancer Early In Singapore
April 2021
ODAC Opposes Ongoing FDA Approval of Nivolumab For HCC In Patients Pretreated With Sorafenib
Atezolizumab/Bevacizumab Combo Sets the Standard for New Doublets in Advanced HCC
ODAC Unanimously Backs Pembrolizumab for Second-line Advanced HCC
The Need for Novel Neoadjuvant Therapies in HCC
7 Reasons Why You Should Drink Moringa Tea
UMCG Studies Cannabis Oil For Liver Cancer Patients With No Further Treatment Options
How to Radiologically Assess and Follow Response After Treatment of Hepatocellular Carcinoma
Artificially Sweetened Soda May Raise Liver Cancer Risk
Dr. Charlton on the Effects of the COVID-19 Pandemic on HCC
Medivir Has Determined the Starting Dose for the Next Part of the Phase Ib Study With MIV-818
New Combo Shows Benefit Even in Patients With High-Risk HCC
Neoadjuvant Cemiplimab Elicits Complete Pathological Responses in HCC
Liver Cancer Cases Leap Among Men in Scotland
A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis
Dr. Levy on the Safety Profile, Dosing of Cabozantinib in HCC
Blue Faery Gives Annual Liver Cancer Research Award
Updated Data Confirm Clinical Benefit of Novel Immunotherapy Combos in HCC
LEGACY Trial of Radioembolization Shows Practice-Changing Data in HCC
Gene Discovery Suggests New Treatment Approach for Liver Cancer
Protein-Based Biomarker Identifies the Chemo Drug Sensitivity
Burst of Treatment Options in HCC Complicates Sequencing Decisions
March 2021
Continued Demand for Hepatocellular Carcinoma Surveillance
Regorafenib/Nivolumab Proof Of Concept Suggested In Third-Line, Refractory HCC
Study In ‘Nature’ Concludes Immunotherapy Is Less Efficient In Non-Viral Liver Cancer
Genetron Health Releases New Data Results Of HCCscreen™ For Liver Cancer Early Screening In China
What to Know About Yervoy (Ipilimumab)
No Evidence That The Milk Protein Casein Causes Cancer
TheraSphere SIRT Received FDA Approval For Treatment Of Unresectable HCC
FDA Approves TheraSphere Y-90 Glass Microspheres For Unresectable HCC
As FDA Review Approaches, Finn Reflects On The Utility of Pembrolizumab, Nivolumab In HCC
Dr. Pillai On Sequential Treatment In HCC
Liver Cancer Symptoms: Pain Near the Right Shoulder Blade Could Be A Sign Of The Disease
The Non-Alcoholic Fatty Liver Cause Of Hepatocellular Carcinoma
People With HIV And Hepatitis B Should Have Ongoing Monitoring For Liver Cancer
Microwave Ablation Burns Away Liver Tumors
Looking Beyond Atezolizumab/Bevacizumab For The Treatment Of HCC
St George Hospital Researchers Make Liver Cancer Breakthrough
How Real-World Regorafenib Dosing Correlates With Prior Sorafenib Treatment In HCC
How Summer On The Lake May Impact Your Liver
Doctors Debate: Is Systemic Or Liver-Directed Therapy Best For Hepatocellular Carcinoma?
TGH Begins Trial of New Device Created To Destroy Tumors Without Surgery
Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring Of Liver Disease
Study Shows Simple Blood Test Could Detect Liver Injury Earlier
NICE Recommends New Advanced Liver Cancer Treatment
Implanted Chemotherapy Device Has Kept Her Cancer In Check For More Than A Year
Personalized Radioembolization Improves OS Vs Standard Dosing In Advanced HCC
February 2021
Q&A: Longest Survival Among HCC Patients Seen With ‘Breakthrough’ Drug Combination
Why Is Liver Cancer More Lethal For Black Patients?
Zhejiang University: ZJU Scientists Report Advances In Hepatocellular Carcinoma
ZJU Scientists Report Advances In Hepatocellular Carcinoma
Cancer Control: Non-DNA Changes Induce Metabolism Variations In Hepatocellular Carcinomas
Neoadjuvant Cabozantinib/Nivolumab Feasible For Borderline Resectable Patients With HCC
Dr. Mody On Progress Made With Y-90 In Hepatocellular Carcinoma
Never-Before-Seen Antibody Binding, Informing Liver Cancer, Antibody Design
New Standard Of Care In Hepatocellular Carcinoma Shifts The Treatment Paradigm To A Grey Area
Incidence Of Liver Cancer Increases Significantly Among People With HIV
Gentle Stroll On Treadmill Helps Prevent Liver Cancer
Challenges When Treating Patients With Hepatocellular Carcinoma
Ionic Liquid Formulation Uniformly Delivers Chemotherapy To Tumors While Destroying Cancerous Tissue
Drug Combo May Boost Survival For Tough-To-Treat Liver Cancers
RDI And Ammonia Levels May Predict Tolerability Of Lenvatinib In HCC
Drug 'Breakthrough' Gives Longest-Ever Survival In Nonresectable Liver Cancer Patients
Watch A New “Love Your Liver” Video Each Day In February!
Eisai’s Liver Cancer Drug Lenvima Threatens Bayer’s Nexavar
Liver Cancer ‘Signature’ In Gut Holds Clues To Cancer Risk
Liver Cancer Still 2nd Major Cause Of Cancer Deaths In Korea
Real-World Data For Lenvatinib Is Similar To Clinical Trials
Can-Fite Announces Inhibition Of Liver Fibrosis By Cannabis Compounds In Preclinical Studies
Targeted RNA Nanoparticle Shows Early Promise As Treatment For Liver Cancer
January 2021
Redefining BCLC B, Intermediate-Stage HCC: Is There A Role For Combination Systemic Therapy
Pembrolizumab Not Cost-Effective For Second-Line Treatment Of HCC In The US
FDA Clearance For Hepatica, Perspectum’s Surgical Decision Support Tool For Liver Cancer
Jellyfish Venom Stops Cancer Cell Growth In Lab Trial
FDA Grants Orphan Drug Designation To Uttroside-B For Liver Cancer
Evidence Grows For Avoiding Biopsy In Hepatocellular Carcinoma
Post-Treatment Alpha-Fetoprotein Reduction Prognostic For Survival Outcomes In HCC
Hepatocellular Carcinoma: Support For The Fourth Leading Cancer-Related Cause Of Death
Patients With Advanced HCC Often Do Not Receive Second-Line Therapy In Real-World Practice
Pembrolizumab Monotherapy May Play Role In Treatment-Naive HCC
Hepatocellular Carcinoma Treatment Landscape Evolving By The Minute
Second-Line Pembrolizumab Shows Continued OS And PFS Improvement In Advanced HCC
Japanese Team Develops Cancer Detector Using Mosquito's Sense Of Smell
Lenvatinib Monotherapy Demonstrates Efficacy In The First Line For HCC
Validated Risk Score Predicts Post-Transplant Survival In HCC
Scoring System To Redefine How U.S. Patients Prioritized For Liver Transplant
Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis And Treatment
Frontline Treatment Arsenal Expands In Advanced HCC
Liver Stiffness Before Hepatitis C Treatment Predicts Liver Cancer Risk
Real-World Findings In REFINE Study Support Use Of Regorafenib In HCC
Liver Cancer Cells Cause Stromal Cells To Secrete Protein That Enhances Tumor Growth
Immunotherapy With Radiotherapy Could Improve Outcomes Of Cancers In Liver
Comparable Survival Observed With Regorafenib In HCC In Real-World Versus Clinical Settings
Immunicum AB Receives FDA Orphan Drug Designation For Ilixadencel As A Treatment HCC